Cargando…
GenoRisk: A polygenic risk score for Alzheimer's disease
INTRODUCTION: Recent clinical trials are considering inclusion of more than just apolipoprotein E (APOE) ε4 genotype as a way of reducing variability in analysis of outcomes. METHODS: Case‐control data were used to compare the capacity of age, sex, and 58 Alzheimer's disease (AD)–associated sin...
Autores principales: | Dickson, Samuel P., Hendrix, Suzanne B., Brown, Bruce L., Ridge, Perry G., Nicodemus‐Johnson, Jessie, Hardy, Marci L., McKeany, Allison M., Booth, Steven B., Fortna, Ryan R., Kauwe, John S.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485054/ https://www.ncbi.nlm.nih.gov/pubmed/34621978 http://dx.doi.org/10.1002/trc2.12211 |
Ejemplares similares
-
The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
por: Page, Madeline L., et al.
Publicado: (2022) -
A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
por: Schechter, Ginger, et al.
Publicado: (2020) -
Avoiding future controversies in the Alzheimer’s disease space through understanding the aducanumab data and FDA review
por: Dickson, Samuel P., et al.
Publicado: (2023) -
Writing DNA with GenoCAD™
por: Czar, Michael J., et al.
Publicado: (2009) -
ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020)